Microbot Medical Inc
NASDAQ:MBOT
Intrinsic Value
Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. [ Read More ]
The intrinsic value of one MBOT stock under the Base Case scenario is 0.443 USD. Compared to the current market price of 0.891 USD, Microbot Medical Inc is Overvalued by 50%.
Valuation Backtest
Microbot Medical Inc
Run backtest to discover the historical profit from buying and selling MBOT stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Microbot Medical Inc
Current Assets | 7.9m |
Cash & Short-Term Investments | 6.4m |
Other Current Assets | 1.5m |
Non-Current Assets | 406k |
PP&E | 406k |
Current Liabilities | 3.8m |
Accounts Payable | 357k |
Accrued Liabilities | 3.4m |
Non-Current Liabilities | 40k |
Other Non-Current Liabilities | 40k |
Earnings Waterfall
Microbot Medical Inc
Revenue
|
0
USD
|
Operating Expenses
|
-9.9m
USD
|
Operating Income
|
-9.9m
USD
|
Other Expenses
|
-885k
USD
|
Net Income
|
-10.7m
USD
|
Free Cash Flow Analysis
Microbot Medical Inc
MBOT Profitability Score
Profitability Due Diligence
Microbot Medical Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
Score
Microbot Medical Inc's profitability score is 27/100. The higher the profitability score, the more profitable the company is.
MBOT Solvency Score
Solvency Due Diligence
Microbot Medical Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Score
Microbot Medical Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MBOT Price Targets Summary
Microbot Medical Inc
Ownership
MBOT Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
MBOT Price
Microbot Medical Inc
Average Annual Return | -12.54% |
Standard Deviation of Annual Returns | 39.95% |
Max Drawdown | -95% |
Market Capitalization | 12.8m USD |
Shares Outstanding | 14 399 000 |
Percentage of Shares Shorted | 1.36% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The company is headquartered in Hingham, Massachusetts and currently employs 17 full-time employees. The company specializes in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Its technological platforms include ViRob, TipCAT, LIBERTY and certain CardioSert assets. The ViRob is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The TipCAT is a disposable self-propelled locomotive device that is specially designed to advance tubular anatomy. LIBERTY is designed to maneuver guidewires and over-the-wire devices, such as microcatheters within the body's vasculature. The company is developing Self-Cleaning Shunt (SCSTM), for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH) using ViRob platform. The company is developing the fully disposable robot for various endovascular interventional procedures using LIBERTY and CardioSert platforms. The company is also focused on the development of a multi generation pipeline portfolio.
Contact
IPO
Employees
Officers
The intrinsic value of one MBOT stock under the Base Case scenario is 0.443 USD.
Compared to the current market price of 0.891 USD, Microbot Medical Inc is Overvalued by 50%.